We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · May 07, 2018

HER2+ Breast Cancer With Brain Metastasis

Written by
Sameer Nasir MD

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Luca Licata

    According to ASCO Guidelines there is no a clear role for a systemic therapy in case systemic disease is not progressive at the time of brain metastasis diagnosis. However the quality of evidence is low and, sincerely, I would not feel so confident to leave such a young and high risk patient without a systemic treatment at all. Probably I would consider TDM-1, but the other problem would be....how long?


  • Sep 30, 2020

    Pending Moderator approval.
    Delete

Further Reading